Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The Effect of Carotid Chemoreceptor Inhibition on Exercise Tolerance in Chronic Heart Failure.

Collins SÉ, Phillips DB, McMurtry MS, Bryan TL, Paterson DI, Wong E, Ezekowitz JA, Forhan MA, Stickland MK.

Front Physiol. 2020 Mar 12;11:195. doi: 10.3389/fphys.2020.00195. eCollection 2020.

2.

Drug-Induced Acute Coronary Syndrome: A New Cardiovascular Concern With Immune Checkpoint Inhibitors and the Need for a Prospective Registry.

Alhumaid W, Paterson DI.

Can J Cardiol. 2020 Apr;36(4):455-456. doi: 10.1016/j.cjca.2020.02.001. Epub 2020 Feb 8. No abstract available.

PMID:
32146066
3.

Development and validation of a compact on-person storage device (SMHeartCard) for emergency access to acetylsalicylic acid and nitroglycerin.

Le T, Paterson DI, Davies NM, Mackey JR.

CMAJ Open. 2020 Feb 11;8(1):E75-E82. doi: 10.9778/cmajo.20190147. Print 2020 Jan-Mar.

4.

OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B).

Paterson DI, Wells G, Erthal F, Mielniczuk L, O'Meara E, White J, Connelly KA, Knuuti J, Radja M, Laine M, Chow BJW, Kandolin R, Chen L, Dick A, Dennie C, Garrard L, Ezekowitz J, Beanlands R, Chan KL; IMAGE-HF Investigators.

Circulation. 2020 Mar 10;141(10):818-827. doi: 10.1161/CIRCULATIONAHA.119.043964. Epub 2020 Jan 8.

PMID:
31910649
5.

Quantification of lung water in heart failure using cardiovascular magnetic resonance imaging.

Thompson RB, Chow K, Pagano JJ, Sekowski V, Michelakis ED, Tymchak W, Haykowsky MJ, Ezekowitz JA, Oudit GY, Dyck JRB, Kaul P, Savu A, Paterson DI.

J Cardiovasc Magn Reson. 2019 Sep 12;21(1):58. doi: 10.1186/s12968-019-0567-y.

6.

Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer.

Kirkham AA, Beaudry RI, Paterson DI, Mackey JR, Haykowsky MJ.

Prog Cardiovasc Dis. 2019 Mar - Apr;62(2):116-126. doi: 10.1016/j.pcad.2019.02.002. Epub 2019 Feb 22. Review.

PMID:
30797800
7.

Titration and Tolerability of Sacubitril/Valsartan for Patients With Heart Failure in Clinical Practice.

Du AX, Westerhout CM, McAlister FA, Shanks M, Oudit GY, Paterson DI, Hanninen M, Thomas J, Ezekowitz JA.

J Cardiovasc Pharmacol. 2019 Mar;73(3):149-154. doi: 10.1097/FJC.0000000000000643.

PMID:
30540684
8.

Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imaging.

Alherbish A, Becher H, Alemayehu W, Paterson DI, Butler CR, Anderson TJ, Ezekowitz JA, Shanks M; Alberta HEART investigators.

Echocardiography. 2018 Nov;35(11):1746-1754. doi: 10.1111/echo.14152. Epub 2018 Oct 30.

PMID:
30376596
9.

Breast Cancer Patients Receiving Anthracycline Chemotherapy and Trastuzumab Have Biventricular Dysfunction and Reduced Heart Mass.

McLean BA, Hansen R, Paterson DI, White JA, Oudit GY.

J Am Coll Cardiol. 2018 Oct 9;72(15):1872-1873. doi: 10.1016/j.jacc.2018.07.057. No abstract available.

10.

Cardiac Rehabilitation in Patients With Lymphoma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Cardio-oncology Pilot Project.

Rothe D, Cox-Kennett N, Buijs DM, Venner CP, Paterson DI, Gyenes GT, Pituskin E.

Can J Cardiol. 2018 Oct;34(10 Suppl 2):S263-S269. doi: 10.1016/j.cjca.2018.07.001. Epub 2018 Jul 12.

PMID:
30201254
12.

Effects of age, gender, and risk-factors for heart failure on native myocardial T1 and extracellular volume fraction using the SASHA sequence at 1.5T.

Pagano JJ, Chow K, Paterson DI, Mikami Y, Schmidt A, Howarth A, White J, Friedrich MG, Oudit GY, Ezekowitz J, Dyck J, Thompson RB.

J Magn Reson Imaging. 2018 Nov;48(5):1307-1317. doi: 10.1002/jmri.26160. Epub 2018 Jun 13.

PMID:
29897656
13.

The State of Cardiovascular Magnetic Resonance Imaging in Canada: Results from the CanSCMR Pan-Canadian Survey.

Roifman I, Paterson DI, Jimenez-Juan L, Friedrich MG, Howarth AG, Wintersperger BJ, Thavendiranathan P, White JA, Connelly KA.

Can J Cardiol. 2018 Mar;34(3):333-336. doi: 10.1016/j.cjca.2017.12.026. Epub 2017 Dec 27.

PMID:
29475533
14.

Does Cancer Affect Cardiac Function Prior to Cancer Therapy Exposure?

Kirkham AA, Pituskin E, Paterson DI.

Can J Cardiol. 2018 Mar;34(3):234-235. doi: 10.1016/j.cjca.2017.12.019. Epub 2017 Dec 26. No abstract available.

PMID:
29398174
15.

Novel Dominant-Negative Mutation in Cardiac Troponin I Causes Severe Restrictive Cardiomyopathy.

Shah S, Yogasundaram H, Basu R, Wang F, Paterson DI, Alastalo TP, Oudit GY.

Circ Heart Fail. 2017 Feb;10(2). pii: e003820. doi: 10.1161/CIRCHEARTFAILURE.116.003820. No abstract available.

PMID:
28174160
16.

Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity.

Pituskin E, Mackey JR, Koshman S, Jassal D, Pitz M, Haykowsky MJ, Pagano JJ, Chow K, Thompson RB, Vos LJ, Ghosh S, Oudit GY, Ezekowitz JA, Paterson DI.

J Clin Oncol. 2017 Mar 10;35(8):870-877. doi: 10.1200/JCO.2016.68.7830. Epub 2016 Nov 28.

PMID:
27893331
17.

The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.

Parent S, Pituskin E, Paterson DI.

Can J Cardiol. 2016 Jul;32(7):847-51. doi: 10.1016/j.cjca.2016.04.014. Epub 2016 May 6.

PMID:
27343743
18.

The Adult With Repaired Coarctation: Need for Lifelong Surveillance.

Vonder Muhll IF, Sehgal T, Paterson DI.

Can J Cardiol. 2016 Aug;32(8):1038.e11-5. doi: 10.1016/j.cjca.2015.12.036. Epub 2016 Jan 21. Review.

PMID:
27084076
19.

Importance of Cardiac Magnetic Resonance in a Patient With Crohn's Disease-Associated Constrictive Pericarditis.

Barake W, Vonder Muhll I, Paterson DI.

Circulation. 2016 Mar 1;133(9):e419-20. doi: 10.1161/CIRCULATIONAHA.115.019525. No abstract available.

PMID:
26927011
20.

Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

Haykowsky MJ, Tomczak CR, Scott JM, Paterson DI, Kitzman DW.

J Appl Physiol (1985). 2015 Sep 15;119(6):739-44. doi: 10.1152/japplphysiol.00049.2015. Epub 2015 Apr 24. Review.

21.

Normal left-atrial structure and function despite concentric left-ventricular remodelling in a cohort of patients with Anderson-Fabry disease.

Putko BN, Yogasundaram H, Chow K, Pagano J, Khan A, Paterson DI, Thompson RB, Oudit GY.

Eur Heart J Cardiovasc Imaging. 2015 Oct;16(10):1129-36. doi: 10.1093/ehjci/jev057. Epub 2015 Mar 6.

22.

Right atrial mass in a 23-year-old woman with molar pregnancy.

Sharma A, Sidhu RS, Paterson DI.

CMAJ. 2015 Mar 17;187(5):350-4. doi: 10.1503/cmaj.140889. Epub 2015 Jan 19. No abstract available.

23.

Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.

Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY.

Can J Cardiol. 2014 Dec;30(12):1706-15. doi: 10.1016/j.cjca.2014.08.016. Epub 2014 Aug 23. Review.

PMID:
25475472
24.

Novel mutation in exon 14 of the sarcomere gene MYH7 in familial left ventricular noncompaction with bicuspid aortic valve.

Basu R, Hazra S, Shanks M, Paterson DI, Oudit GY.

Circ Heart Fail. 2014 Nov;7(6):1059-62. doi: 10.1161/CIRCHEARTFAILURE.114.001666. No abstract available.

PMID:
25415959
25.

The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study.

Ezekowitz JA, Becher H, Belenkie I, Clark AM, Duff HJ, Friedrich MG, Haykowsky MJ, Howlett JG, Kassiri Z, Kaul P, Kim DH, Knudtson ML, Light PE, Lopaschuk GD, McAlister FA, Noga ML, Oudit GY, Paterson DI, Quan H, Schulz R, Thompson RB, Weeks SG, Anderson TJ, Dyck JR.

BMC Cardiovasc Disord. 2014 Jul 25;14:91. doi: 10.1186/1471-2261-14-91.

26.

Quantification of circumferential, longitudinal, and radial global fractional shortening using steady-state free precession cines: a comparison with tissue-tracking strain and application in Fabry disease.

Cheng-Baron J, Chow K, Pagano JJ, Punithakumar K, Paterson DI, Oudit GY, Thompson RB.

Magn Reson Med. 2015 Feb;73(2):586-96. doi: 10.1002/mrm.25166. Epub 2014 Mar 13.

27.

Carotid chemoreceptor modulation of blood flow during exercise in healthy humans.

Stickland MK, Fuhr DP, Haykowsky MJ, Jones KE, Paterson DI, Ezekowitz JA, McMurtry MS.

J Physiol. 2011 Dec 15;589(Pt 24):6219-30. doi: 10.1113/jphysiol.2011.218099. Epub 2011 Oct 24.

28.

Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Kaila K, Haykowsky MJ, Thompson RB, Paterson DI.

Heart Fail Rev. 2012 Sep;17(4-5):555-62. doi: 10.1007/s10741-011-9273-z. Review.

PMID:
21818681
29.

Recent advances in cardiac imaging for patients with heart failure.

Paterson DI, OMeara E, Chow BJ, Ukkonen H, Beanlands RS.

Curr Opin Cardiol. 2011 Mar;26(2):132-43. doi: 10.1097/HCO.0b013e32834380e7. Review.

PMID:
21297464
30.

Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training.

Haykowsky MJ, Mackey JR, Thompson RB, Jones LW, Paterson DI.

Clin Cancer Res. 2009 Aug 1;15(15):4963-7. doi: 10.1158/1078-0432.CCR-09-0628. Epub 2009 Jul 21.

31.

Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditis.

Ingkanisorn WP, Paterson DI, Calvo KR, Rosing DR, Schwartzentruber DJ, Fuisz AR, Arai AE.

J Cardiovasc Magn Reson. 2006;8(2):353-60.

PMID:
16669178
32.

Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain.

Ingkanisorn WP, Kwong RY, Bohme NS, Geller NL, Rhoads KL, Dyke CK, Paterson DI, Syed MA, Aletras AH, Arai AE.

J Am Coll Cardiol. 2006 Apr 4;47(7):1427-32. Epub 2006 Mar 20.

33.

Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research.

Syed MA, Paterson DI, Ingkanisorn WP, Rhoads KL, Hill J, Cannon RO 3rd, Arai AE.

J Cardiovasc Magn Reson. 2005;7(5):763-8.

PMID:
16353436
34.

Supplemental Content

Loading ...
Support Center